Vaxcyte, Inc. PCVX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s invested capital?
- Vaxcyte, Inc. (PCVX) reported invested capital of $2.85B in Q1 2026.
- How has Vaxcyte, Inc.'s invested capital changed year-over-year?
- Vaxcyte, Inc.'s invested capital decreased by 3.0% year-over-year, from $2.94B to $2.85B.
- What is the long-term trend for Vaxcyte, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s invested capital has grown at a 131.6% compound annual growth rate (CAGR), from -$39.46M to $2.63B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).